MEDIA RELEASE PR37060
Shimadzu and EDDA Announce Business Partnership on X-ray Chest CAD Applications
KYOTO and PRINCETON, N.J., Nov. 12 /PRNewswire-AsiaNet/ --
Shimadzu Corporation (Kyoto Japan) and EDDA Technology Inc. (Princeton, NJ, USA) today announced
that both parties have entered into a business partnership on X-ray chest CAD systems based on the
Radiography System of Shimadzu featuring its direct conversion flat panel detector (FPD) and EDDA's CAD
applications.
This partnership contains both distribution of EDDA's chest X-ray CAD applications with Shimadzu's DR
system through Shimadzu's worldwide sales channel and the development of fully new applications integrating
Shimadzu's state-of-the-art application for digital radiography together with EDDA's sophisticated technology
in the field of chest CAD.
Chest X-ray CAD (Computer Aided Detection) is an advanced clinical application aiming the improvement of
physician's detection accuracy of lung nodules by identifying possible nodules efficiently using computer
image analysis technology, which will also help to overcome the challenge of workload of physicians in the
diagnosis process. Chest X-ray is the most commonly performed radiographic exam accounting for nearly
50% of all imaging tests, and over 70 million chest X-rays are performed yearly in the US.
EDDA is a pioneer in the area of chest CAD application. Its IQQA(R)-Chest CAD product is already
approved by FDA, EU CE and China SFDA, and is sold and used in USA, Europe, China and other countries.
The first prospective study on chest X-ray CAD published in peer-reviewed journal showed positive results that
suggest the interpretation of chest radiographs for lung nodules can be improved using IQQA(R)-Chest.
Shimadzu will distribute this chest X-ray CAD application with its DR products in worldwide markets (*). Both
companies are working together to prepare another innovative new chest CAD application which shall be
introduced to worldwide markets in the upcoming years.
"According to the statistics such as those from WHO, ratio of death from cancer in the recent years tends to
be decreasing. However, that from lung cancer is remarkably increasing, " said Mr. Kunimasa Itoh, general
manager, marketing dept., medical systems division of Shimadzu Corporation. "Through the partnership with
EDDA, who is expert of application development in this field, we will be able to contribute to improving clinical
workflow and quality care of patients by providing advanced image diagnosis solutions to aid in early detection
of lung lesions."
"Our partnership with Shimadzu Corporation reflects the increasingly important role that advanced computer
application plays in enhancing clinical workflow to be faster, better and more cost-effective," said Dr. Jian-
Zhong Qian, president and CEO of EDDA Technology. "We are pleased to partner with Shimadzu to offer new
solutions to the diagnosis and management of potentially life-threatening lung diseases."
(* Regulatory approval for the distribution through Shimadzu in Japan and other countries are pending as of
this moment.)
About Shimadzu Corporation
Founded in 1875, Shimadzu Corporation, a leader in the development of advanced technologies, has a
distinguished history of innovation build on the foundation of contributing to society through science and
technology. Shimadzu maintain a global network of sales, service, technical support and applications centers
on six continents, and have established long-term relationship with a host of highly trained distributors located
in over 100 countries.
About EDDA Technology
EDDA Technology, Inc. is an innovative clinical computer solution provider in diagnostic imaging and
analysis. EDDA offers a series of new generation software products to enable early detection of diseases, and
enhance efficiency and precision in diagnosis and treatment. EDDA's goal is to deliver, with broad
accessibility, advanced information analysis technologies that improve clinical workflow and accuracy. A
privately held Delaware corporation, EDDA is headquartered in Princeton, New Jersey, and has a subsidiary
in Shanghai, China. IQQA is a registered trademark of EDDA Technology.
Editor's Note: EDDA Technology will be exhibiting in Booth # 9318, and Shimadzu Corporation in Booth
#5000, of McCormick Place in Chicago at the 95th Scientific Assembly and Annual Meeting of the Radiological
Society of North America (RSNA), Nov. 29 - Dec. 3, 2009.
SOURCE: EDDA Technology, Inc.
CONTACT: Tetsuya Tanigaki,
Public Relations Department, Shimadzu Corporation,
tanigaki@shimadzu.co.jp,
or Xiaolan Zeng,
Business and Market Development,
EDDA Technology,
+1-609-919-9889,
xzeng@eddatech.com
NEWS 
